Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.44 |
| ▸ | RELA | Q04206 | 1/20 | 0.44 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.41 |
| ▸ | NAAA | Q02083 | 10/20 | 0.39 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14809036 | 0.78 | CA1 (0.44) | CYP11B1CYP11B2KMT2A | |
| SCHEMBL9932237 | 0.77 | GAA (0.50) | NFKB1NFKB2RELAKMT2A | |
| SCHEMBL999679 | 0.77 | GAA (0.50) | NFKB1NFKB2RELAKMT2A | |
| SCHEMBL25981811 | 0.77 | GAA (0.50) | NFKB1NFKB2RELAKMT2A | |
| SCHEMBL1935629 | 0.77 | MCL1 (0.42) | KMT2A | |
| SCHEMBL2792237 | 0.77 | MCL1 (0.42) | KMT2A | |
| SCHEMBL760401 | 0.77 | EPHX1 (0.59) | NAAAASAH1KMT2A | |
| SCHEMBL14534711 | 0.77 | EPHX1 (0.59) | NAAAASAH1KMT2A | |
| SCHEMBL24565369 | 0.75 | HTT (0.46) | KMT2A | |
| SCHEMBL6093270 | 0.75 | HTT (0.46) | KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1996028157-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING L-ETRABAMINE, USES THEREOF, AND METHODS FOR PREPARING SAME | LABORATOIRES JACQUES LOGEAIS (FR) | 1996-09-19 | — | — | WO | disclosed |